Reconstruction and expression of the MRI-contrast protein, ferritin, with recombinant rabies vectors

被引:0
|
作者
Lingling Liu
Kai Gong
Pinggang Ming
Ying Huang
Qing Tang
Gelin Xu
Jiaxin Yan
Nanming Zhao
Xiufang Zhang
Yandao Gong
机构
[1] Tsinghua University,State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Life Sciences
[2] Institute for Viral Disease Control and Prevention,State Key Laboratory for Molecular Virology and Genetic Engineering
[3] China CDC,Department of Genetic Engineering
[4] Wuhan Institute of Biological Product,undefined
来源
Biotechnology Letters | 2010年 / 32卷
关键词
Contrast agent; Ferritin; Magnetic resonance imaging (MRI); Rabies vectors;
D O I
暂无
中图分类号
学科分类号
摘要
Attenuated recombinant rabies vector could be an ideal system for delivery of contrast agent gene for Magnetic Resonance Imaging (MRI) because of its neurotropic nature. In this study, the gene of a biomolecular contrast agent, ferritin, was successfully cloned into two rabies virus vectors, vaccine-based pCTN and street strain-based pNH. Recombinant virus granules were obtained and proved to express ferritin by RT-PCR after transfection of CTN-ferritin and NH-ferritin vector systems in BHK-21 cells. The recovered rabies virus-rCTN-ferritin was of similar ability to rNH-ferritin, which suggests the possibility of application of this safe and effective rabies vector system in delivery of diagnostic or therapeutic genes into the brain.
引用
收藏
页码:743 / 748
页数:5
相关论文
共 2 条
  • [1] Reconstruction and expression of the MRI-contrast protein, ferritin, with recombinant rabies vectors
    Liu, Lingling
    Gong, Kai
    Ming, Pinggang
    Huang, Ying
    Tang, Qing
    Xu, Gelin
    Yan, Jiaxin
    Zhao, Nanming
    Zhang, Xiufang
    Gong, Yandao
    BIOTECHNOLOGY LETTERS, 2010, 32 (06) : 743 - 748
  • [2] Expression of clMagR/clCry4 protein in mBMSCs provides T2 -contrast enhancement of MRI
    Li, Nuan
    Wang, Peng
    Xie, Yuanyuan
    Wang, Bin
    Zhu, Chenzhuo
    Xue, Le
    Han, Xiaofeng
    Gu, Ning
    Sun, Jianfei
    ACTA BIOMATERIALIA, 2023, 172 : 309 - 320